Comparison
Berberine vs DHEA
Side-by-side of Berberine and DHEA. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Berberine
Berberine supplement guide: 1500 mg/day lowers fasting glucose and HbA1c, AMPK activation, metformin parity in RCTs, dihydroberberine absorption.
DHEA
DHEA supplement profile: adrenal androgen precursor, typical 25-50 mg dose, DHEA-S targets, evidence for adrenal insufficiency and vaginal atrophy, side effec.
Effects at a glance
Berberine
- •Lowers HbA1c by ~0.7% versus placebo at 1500 mg/day across 27-trial meta-analysis (Lan 2015)
- •Roughly comparable to metformin on fasting glucose and HbA1c in small head-to-head RCTs (Yin 2008)
- •Reduces LDL cholesterol 10-20% and triglycerides 15-25% via PCSK9 inhibition
- •Activates AMPK, the cellular energy sensor that drives insulin-independent glucose uptake
- •Oral bioavailability under 1%; dihydroberberine is the higher-absorption alternative at lower doses
- •GI side effects affect 10-30% at 1500 mg/day; split dosing with meals reduces incidence
DHEA
- •Adrenal androgen precursor; serum DHEA-S declines progressively after the third decade of life
- •OTC dietary supplement in US under DSHEA 1994; prescription in EU, UK, Canada, Australia
- •FDA approved as Intrarosa (6.5 mg vaginal insert) for postmenopausal dyspareunia in 2016
- •Acts as tissue-specific prohormone converted intracrinologically to testosterone and estrogens
- •Best evidence: adrenal insufficiency replacement and vaginal atrophy; weaker on cognition and longevity
- •WADA banned in competitive sport; banned in NCAA, MLB, NFL, IOC settings
Side-by-side
| Attribute | Berberine | DHEA |
|---|---|---|
| Category | natural | hormone |
| Also known as | berberine HCl, berberine hydrochloride | dehydroepiandrosterone, prasterone, Intrarosa |
| Half-life (hr) ↗ | 3 | 12 |
| Typical dose (mg) ↗ | 1500 | 25 |
| Dosing frequency | 3x daily with meals | daily, typically morning |
| Routes | oral | oral, vaginal, topical |
| Onset (hr) | 2 | 1 |
| Peak (hr) | 3 | 1 |
| Molecular weight | 336.36 | 288.42 |
| Molecular formula | C20H18NO4+ | C19H28O2 |
| Mechanism | Activates AMP-activated protein kinase (AMPK), suppressing hepatic gluconeogenesis and lipogenesis while increasing peripheral glucose uptake. Inhibits PCSK9 transcription, modulates bile acid signaling, and shifts gut microbiome composition. | Steroid prohormone converted intracrinologically to testosterone and estrogens in target tissues; also exerts direct effects via sigma-1 receptor, GABA-A modulation, and glucocorticoid receptor interaction. |
| Legal status | Dietary supplement (US, EU, UK, Canada); Rx in some Asian jurisdictions | OTC supplement in US (DSHEA 1994); prescription in EU, UK, Canada, Australia |
| WADA status | allowed | banned |
| DEA / Rx | Not scheduled | OTC supplement in US (not scheduled); Rx in EU, UK, Canada, Australia |
| Pregnancy | Contraindicated (kernicterus risk in neonates) | Contraindicated in pregnancy |
| CAS | 2086-83-1 | 53-43-0 |
| PubChem CID | 2353 | 5881 |
| Wikidata | Q411435 | Q411733 |
Safety profile
Berberine
Common side effects
- constipation
- diarrhea
- abdominal cramping
- flatulence
- nausea
Contraindications
- pregnancy
- lactation
- neonatal jaundice
- severe liver disease
Interactions
- metformin: additive HbA1c reduction; additive GI side effects(moderate)
- insulin or sulfonylureas: additive hypoglycemia risk; dose adjustment may be required(major)
- statins (simvastatin, atorvastatin): CYP3A4 inhibition raises statin plasma levels(moderate)
- cyclosporine: raises cyclosporine levels through CYP3A4 and P-gp inhibition(major)
- calcium channel blockers (amlodipine): elevated plasma levels via CYP3A4 inhibition(moderate)
DHEA
Common side effects
- acne
- oily skin
- hirsutism (women)
- gynecomastia (men, higher doses)
- irritability
- insomnia
Contraindications
- hormone-sensitive cancer (breast, ovarian, prostate)
- active liver disease
- uncontrolled lipid disorder
- pregnancy and lactation
Interactions
- warfarin: case reports of altered INR; monitor(moderate)
- estrogens (HRT): additive estrogenic effect via conversion; monitor(moderate)
- insulin: may improve insulin sensitivity slightly; monitor glucose(minor)
- anastrozole: may reduce DHEA-derived estrogen; clinical relevance unclear(minor)
Which Should You Take?
Berberine and DHEA score evenly on the criteria we weight (goal breadth, legal accessibility, evidence depth). The conditionals below should drive the decision more than any aggregate score.
- → If your priority is metabolic health and glucose control, pick Berberine.
- → If your priority is cardiovascular health, pick Berberine.
- → If your priority is hormonal optimization, pick DHEA.
Edge case: Berberine is contraindicated in pregnancy; DHEA is the safer pick if that applies.
Default choice: either is defensible. Berberine edges out on goal breadth + legal accessibility; DHEA is the right call if your priority sits in the goals listed above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Berberine and DHEA?
Berberine and DHEA differ in category (natural vs hormone), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Berberine or DHEA?
Berberine half-life is 3 hours; DHEA half-life is 12 hours.
Can you stack Berberine with DHEA?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper